Lactococcus lactis-based vaccines from laboratory bench to human use: An overview

被引:53
作者
Bahey-El-Din, Mohammed [1 ]
机构
[1] Univ Alexandria, Fac Pharm, Dept Pharmaceut Microbiol, Alexandria, Egypt
关键词
Lactococcus lactis; Mucosal vaccine; Delivery system; Biological containment; GEM; Mimopath; MULTI-PARTICULATE FORMULATION; SYSTEMIC IMMUNE-RESPONSES; MUCOSAL DELIVERY; LISTERIA-MONOCYTOGENES; NEUTRALIZING ANTIBODIES; BIOLOGICAL CONTAINMENT; ORAL VACCINATION; GEM PARTICLES; E7; ANTIGEN; PROTECTION;
D O I
10.1016/j.vaccine.2011.11.098
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Developing effective vaccines is an important weapon in the battle against potential pathogens and their evolving antibiotic resistance trends. Several vaccine delivery vectors have been investigated among which the generally regarded as safe (GRAS) Lactococcus lactis has a distinguished position. In this review, different factors affecting the efficacy of L. lactis-based vaccines are discussed. In addition, the issues of biological containment and pharmaceutical quality assurance of L. lactis vaccines are highlighted. These issues are critical for the success of medical translation of L. lactis-based vaccines from research laboratories to clinical use by ensuring consistent manufacturing of safe and efficacious vaccines. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:685 / 690
页数:6
相关论文
共 70 条
[1]   Thymine metabolism and thymineless death in prokaryotes and eukaryotes [J].
Ahmad, SI ;
Kirk, SH ;
Eisenstark, A .
ANNUAL REVIEW OF MICROBIOLOGY, 1998, 52 :591-625
[2]   Development of lactococcal GEM-based pneumococcal vaccines [J].
Audouy, Sandrine A. L. ;
van Selm, Saskia ;
van Roosmalen, Maarten L. ;
Post, Eduard ;
Kanninga, Rolf ;
Neef, Jolanda ;
Estevao, Silvia ;
Nieuwenhuis, Edward E. S. ;
Adrian, Peter V. ;
Leenhouts, Kees ;
Hermans, Peter W. M. .
VACCINE, 2007, 25 (13) :2497-2506
[3]   Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization [J].
Audouy, Sandrine A. L. ;
van Roosmalen, Maarten L. ;
Neef, Jolanda ;
Kanninga, Rolf ;
Post, Eduard ;
van Deemter, Marielle ;
Metselaar, Heidi ;
van Selm, Saskia ;
Robillard, George T. ;
Leenhouts, Kees J. ;
Hermans, Peter W. M. .
VACCINE, 2006, 24 (26) :5434-5441
[4]   Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8+ T cells against Listeria monocytogenes in the murine infection model [J].
Bahey-El-Din, Mohammed ;
Casey, Pat G. ;
Griffin, Brendan T. ;
Gahan, Cormac G. M. .
VACCINE, 2008, 26 (41) :5304-5314
[5]   Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors [J].
Bahey-El-Din, Mohammed ;
Casey, Pat G. ;
Griffin, Brendan T. ;
Gahan, Cormac G. M. .
JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 59 (08) :904-912
[6]  
Bahey-El-Din Mohammed, 2010, Bioeng Bugs, V1, P66, DOI 10.4161/bbug.1.1.10284
[7]   Lactococcus lactis as a Cell Factory for Delivery of Therapeutic Proteins [J].
Bahey-El-Din, Mohammed ;
Gahan, Cormac G. M. ;
Griffin, Brendan T. .
CURRENT GENE THERAPY, 2010, 10 (01) :34-45
[8]   A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors [J].
Bermúdez-Humarán, LG ;
Cortes-Perez, NG ;
Lefèvre, F ;
Guimaraes, V ;
Rabot, S ;
Alcocer-Gonzalez, JM ;
Gratadoux, JJ ;
Rodriguez-Padilla, C ;
Tamez-Guerra, RS ;
Corthier, G ;
Gruss, A ;
Langella, P .
JOURNAL OF IMMUNOLOGY, 2005, 175 (11) :7297-7302
[9]   An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci [J].
Bermúdez-Humarán, LG ;
Cortes-Perez, NG ;
Le Loir, Y ;
Alcocer-González, JM ;
Tamez-Guerra, RS ;
de Oca-Luna, RM ;
Langella, P .
JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (05) :427-433
[10]   Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production [J].
Bermúdez-Humarán, LG ;
Langella, P ;
Cortes-Perez, NG ;
Gruss, A ;
Tamez-Guerra, RS ;
Oliveira, SC ;
Saucedo-Cardenas, O ;
de Oca-Luna, RM ;
Le Loir, Y .
INFECTION AND IMMUNITY, 2003, 71 (04) :1887-1896